Clearside Free Cash Flow vs Begin Period Cash Flow Analysis

CLSD Stock  USD 0.99  0.01  1.00%   
Clearside Biomedical financial indicator trend analysis is way more than just evaluating Clearside Biomedical prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Clearside Biomedical is a good investment. Please check the relationship between Clearside Biomedical Free Cash Flow and its Begin Period Cash Flow accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clearside Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
For information on how to trade Clearside Stock refer to our How to Trade Clearside Stock guide.

Free Cash Flow vs Begin Period Cash Flow

Free Cash Flow vs Begin Period Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Clearside Biomedical Free Cash Flow account and Begin Period Cash Flow. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Clearside Biomedical's Free Cash Flow and Begin Period Cash Flow is -0.25. Overlapping area represents the amount of variation of Free Cash Flow that can explain the historical movement of Begin Period Cash Flow in the same time period over historical financial statements of Clearside Biomedical, assuming nothing else is changed. The correlation between historical values of Clearside Biomedical's Free Cash Flow and Begin Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow of Clearside Biomedical are associated (or correlated) with its Begin Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Begin Period Cash Flow has no effect on the direction of Free Cash Flow i.e., Clearside Biomedical's Free Cash Flow and Begin Period Cash Flow go up and down completely randomly.

Correlation Coefficient

-0.25
Relationship DirectionNegative 
Relationship StrengthInsignificant

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.
Most indicators from Clearside Biomedical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Clearside Biomedical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clearside Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
For information on how to trade Clearside Stock refer to our How to Trade Clearside Stock guide.The current year's Selling General Administrative is expected to grow to about 12.1 M, whereas Issuance Of Capital Stock is forecasted to decline to about 1.6 M.

Clearside Biomedical fundamental ratios Correlations

0.290.390.510.770.28-0.42-0.480.510.760.280.030.990.530.390.010.350.480.10.311.00.560.340.9-0.470.54
0.290.380.3-0.170.90.57-0.550.290.280.79-0.170.270.60.360.60.190.350.450.860.260.370.640.24-0.440.28
0.390.380.730.080.57-0.03-0.710.540.450.52-0.070.330.630.680.240.480.730.40.590.360.650.550.28-0.360.02
0.510.30.730.350.390.0-0.630.760.320.3-0.180.490.550.46-0.090.340.660.10.320.50.570.170.5-0.350.3
0.77-0.170.080.35-0.17-0.49-0.210.380.41-0.21-0.130.760.260.21-0.610.290.33-0.5-0.130.790.39-0.010.91-0.130.45
0.280.90.570.39-0.170.34-0.790.20.460.92-0.10.240.820.660.550.470.630.440.990.250.640.840.24-0.590.07
-0.420.57-0.030.0-0.490.340.090.23-0.620.15-0.44-0.4-0.11-0.260.22-0.42-0.220.060.25-0.43-0.31-0.06-0.30.260.22
-0.48-0.55-0.71-0.63-0.21-0.790.09-0.32-0.67-0.760.0-0.41-0.98-0.93-0.16-0.79-0.96-0.21-0.82-0.45-0.95-0.81-0.490.8-0.07
0.510.290.540.760.380.20.23-0.320.020.12-0.170.520.240.13-0.06-0.150.350.080.140.510.23-0.060.48-0.10.74
0.760.280.450.320.410.46-0.62-0.670.020.550.270.720.720.70.290.70.650.380.540.740.760.680.58-0.740.0
0.280.790.520.3-0.210.920.15-0.760.120.550.30.250.770.650.630.470.60.550.920.240.620.810.17-0.640.04
0.03-0.17-0.07-0.18-0.13-0.1-0.440.0-0.170.270.30.03-0.040.040.260.050.00.32-0.070.020.020.03-0.15-0.19-0.08
0.990.270.330.490.760.24-0.4-0.410.520.720.250.030.460.310.030.260.410.120.260.990.480.270.87-0.420.58
0.530.60.630.550.260.82-0.11-0.980.240.720.77-0.040.460.920.170.80.910.160.860.510.940.870.57-0.780.06
0.390.360.680.460.210.66-0.26-0.930.130.70.650.040.310.920.090.860.960.180.720.370.970.820.42-0.73-0.16
0.010.60.24-0.09-0.610.550.22-0.16-0.060.290.630.260.030.170.09-0.08-0.030.910.54-0.010.00.43-0.34-0.34-0.04
0.350.190.480.340.290.47-0.42-0.79-0.150.70.470.050.260.80.86-0.080.82-0.020.540.340.870.730.44-0.69-0.32
0.480.350.730.660.330.63-0.22-0.960.350.650.60.00.410.910.96-0.030.820.10.660.460.970.70.53-0.730.04
0.10.450.40.1-0.50.440.06-0.210.080.380.550.320.120.160.180.91-0.020.10.420.080.110.32-0.28-0.37-0.07
0.310.860.590.32-0.130.990.25-0.820.140.540.92-0.070.260.860.720.540.540.660.420.280.680.910.27-0.620.03
1.00.260.360.50.790.25-0.43-0.450.510.740.240.020.990.510.37-0.010.340.460.080.280.540.320.9-0.470.55
0.560.370.650.570.390.64-0.31-0.950.230.760.620.020.480.940.970.00.870.970.110.680.540.760.6-0.76-0.02
0.340.640.550.17-0.010.84-0.06-0.81-0.060.680.810.030.270.870.820.430.730.70.320.910.320.760.31-0.69-0.13
0.90.240.280.50.910.24-0.3-0.490.480.580.17-0.150.870.570.42-0.340.440.53-0.280.270.90.60.31-0.370.51
-0.47-0.44-0.36-0.35-0.13-0.590.260.8-0.1-0.74-0.64-0.19-0.42-0.78-0.73-0.34-0.69-0.73-0.37-0.62-0.47-0.76-0.69-0.37-0.15
0.540.280.020.30.450.070.22-0.070.740.00.04-0.080.580.06-0.16-0.04-0.320.04-0.070.030.55-0.02-0.130.51-0.15
Click cells to compare fundamentals

Clearside Biomedical Account Relationship Matchups

Clearside Biomedical fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets26.8M19.3M42.9M51.3M34.0M37.7M
Short Long Term Debt Total6.4M2.0M675K1.3M43.0M45.2M
Other Current Liab2.9M1.2M2.9M3.8M3.8M2.6M
Total Current Liabilities10.9M9.9M4.6M5.8M6.8M7.6M
Total Stockholder Equity11.2M8.8M38.0M10.6M(15.9M)(15.1M)
Property Plant And Equipment Net1.2M944K607K1.9M3.9M4.1M
Net Debt(16.2M)(15.3M)(29.8M)(47.0M)14.1M14.8M
Retained Earnings(237.7M)(255.9M)(255.5M)(288.4M)(320.9M)(304.9M)
Accounts Payable1.3M2.0M941K1.1M2.2M2.5M
Cash22.6M17.3M30.4M48.3M28.9M23.0M
Non Current Assets Total1.6M1.2M767K3.0M3.9M4.1M
Non Currrent Assets Other360K260K160K1.1M30K28.5K
Cash And Short Term Investments22.6M17.3M30.4M48.3M28.9M34.0M
Common Stock Total Equity44K52K60K61K70.2K73.7K
Common Stock Shares Outstanding38.2M46.5M59.9M60.2M61.8M37.3M
Liabilities And Stockholders Equity26.8M19.3M42.9M51.3M34.0M37.7M
Non Current Liabilities Total4.7M616K288K34.0M43.1M45.3M
Other Current Assets1.5M831K1.7M1.1M1.0M670.7K
Other Stockholder Equity248.8M264.6M293.4M299.0M304.9M184.5M
Total Liab15.6M10.6M4.9M40.7M49.9M27.5M
Property Plant And Equipment Gross1.2M944K1.6M2.7M4.8M5.0M
Total Current Assets25.2M18.1M42.1M48.3M30.1M35.9M
Common Stock44K52K60K61K63K37.2K
Other Liab605K10.5M4.6M34.0M39.1M41.0M
Net Tangible Assets11.2M8.8M38.0M10.6M12.2M15.8M
Other Assets360K260K160K30K1.00.95
Short Long Term Debt3.2M556K1.3M991K891.9K847.3K
Short Term Debt1.7M1.7M774K698K728K1.2M
Property Plant Equipment1.2M944K238K755K868.3K643.4K
Capital Surpluse248.8M264.6M293.4M299.0M343.8M222.9M
Retained Earnings Total Equity(237.7M)(255.9M)(255.5M)(288.4M)(259.6M)(272.6M)
Net Invested Capital16.3M9.8M38.0M10.6M(15.9M)(15.1M)
Net Working Capital14.3M8.2M37.5M43.6M23.3M29.1M
Capital Stock44K52K60K61K63K57.2K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Clearside Biomedical is a strong investment it is important to analyze Clearside Biomedical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Clearside Biomedical's future performance. For an informed investment choice regarding Clearside Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clearside Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
For information on how to trade Clearside Stock refer to our How to Trade Clearside Stock guide.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clearside Biomedical. If investors know Clearside will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clearside Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.45)
Revenue Per Share
0.112
Quarterly Revenue Growth
(0.91)
Return On Assets
(0.44)
Return On Equity
(13.10)
The market value of Clearside Biomedical is measured differently than its book value, which is the value of Clearside that is recorded on the company's balance sheet. Investors also form their own opinion of Clearside Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Clearside Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clearside Biomedical's market value can be influenced by many factors that don't directly affect Clearside Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clearside Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clearside Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clearside Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.